Are Allogene Therapeutics Inc (NASDAQ: ALLO) Analysts Predicting A Spike?
Allogene Therapeutics Inc (NASDAQ:ALLO) shares, rose in value on Wednesday, November 20, with price down by -3.30% to the previous day’s close as strong demand from buyers drove the stock to $2.05. Actively observing the price movement in the last trading, the stock closed the